OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A chitosan-mediated inhalable nanovaccine against SARS-CoV-2
Shao‐Hua Zhuo, Jun Wu, Lang Zhao, et al.
Nano Research (2022) Vol. 15, Iss. 5, pp. 4191-4200
Open Access | Times Cited: 40
Shao‐Hua Zhuo, Jun Wu, Lang Zhao, et al.
Nano Research (2022) Vol. 15, Iss. 5, pp. 4191-4200
Open Access | Times Cited: 40
Showing 26-50 of 40 citing articles:
The development of a human Brucella mucosal vaccine: What should be considered?
Tingting Tian, Yuejie Zhu, Juan Shi, et al.
Life Sciences (2024) Vol. 355, pp. 122986-122986
Closed Access | Times Cited: 2
Tingting Tian, Yuejie Zhu, Juan Shi, et al.
Life Sciences (2024) Vol. 355, pp. 122986-122986
Closed Access | Times Cited: 2
Biodegradable Imiquimod-Loaded Mesoporous Organosilica as a Nanocarrier and Adjuvant for Enhanced and Prolonged Immunity against Foot-and-Mouth Disease Virus in Mice
Wenzhu Yin, Dechun Xuan, Haiyan Wang, et al.
ACS Applied Bio Materials (2022) Vol. 5, Iss. 6, pp. 3095-3106
Closed Access | Times Cited: 11
Wenzhu Yin, Dechun Xuan, Haiyan Wang, et al.
ACS Applied Bio Materials (2022) Vol. 5, Iss. 6, pp. 3095-3106
Closed Access | Times Cited: 11
Current status of mucosal vaccines against SARS-CoV2: a hope for protective immunity
Ileana García-Silva, Dania O. Govea‐Alonso, Sergio Rosales‐Mendoza
Expert Opinion on Biological Therapy (2023) Vol. 23, Iss. 2, pp. 207-222
Closed Access | Times Cited: 5
Ileana García-Silva, Dania O. Govea‐Alonso, Sergio Rosales‐Mendoza
Expert Opinion on Biological Therapy (2023) Vol. 23, Iss. 2, pp. 207-222
Closed Access | Times Cited: 5
Nanotechnology of inhalable vaccines for enhancing mucosal immunity
Qin Li, Yanhua Sun, Nan Gao, et al.
Drug Delivery and Translational Research (2023) Vol. 14, Iss. 3, pp. 597-620
Closed Access | Times Cited: 5
Qin Li, Yanhua Sun, Nan Gao, et al.
Drug Delivery and Translational Research (2023) Vol. 14, Iss. 3, pp. 597-620
Closed Access | Times Cited: 5
An Adjustable Adjuvant STINGsome for Tailoring the Potent and Broad Immunity Against SARS‐CoV‐2 and Monkeypox Virus via STING and Necroptosis
Jun Wu, Guan‐Jie Chen, Chen‐Yuan Fan, et al.
Advanced Functional Materials (2023) Vol. 33, Iss. 50
Open Access | Times Cited: 4
Jun Wu, Guan‐Jie Chen, Chen‐Yuan Fan, et al.
Advanced Functional Materials (2023) Vol. 33, Iss. 50
Open Access | Times Cited: 4
Advances in Pulmonary Protein Delivery Systems
Yuanyuan Zhao, Shuai Liu, Xueguang Lu
Advanced NanoBiomed Research (2024) Vol. 4, Iss. 5
Open Access | Times Cited: 1
Yuanyuan Zhao, Shuai Liu, Xueguang Lu
Advanced NanoBiomed Research (2024) Vol. 4, Iss. 5
Open Access | Times Cited: 1
Prolonged resident nanoparticles effectively treat acute lung injury via the selective upregulation of intracellular hydrogen peroxide
Beiduo Wang, Yanping Xu, Qigu Yao, et al.
Nano Today (2024) Vol. 56, pp. 102278-102278
Closed Access | Times Cited: 1
Beiduo Wang, Yanping Xu, Qigu Yao, et al.
Nano Today (2024) Vol. 56, pp. 102278-102278
Closed Access | Times Cited: 1
Pyroptosis: Induction and inhibition strategies for immunotherapy of diseases
Junjun Wu, Hong Wang, Pu Gao, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 10, pp. 4195-4227
Open Access | Times Cited: 1
Junjun Wu, Hong Wang, Pu Gao, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 10, pp. 4195-4227
Open Access | Times Cited: 1
N-dihydrogalactochitosan reduces mortality in a lethal mouse model of SARS-CoV-2
Christopher M. Weiss, H. Liu, Erin E. Ball, et al.
PLoS ONE (2023) Vol. 18, Iss. 8, pp. e0289139-e0289139
Open Access | Times Cited: 3
Christopher M. Weiss, H. Liu, Erin E. Ball, et al.
PLoS ONE (2023) Vol. 18, Iss. 8, pp. e0289139-e0289139
Open Access | Times Cited: 3
Natural Polymeric Composites Derived from Animals, Plants, and Microbes for Vaccine Delivery and Adjuvant Applications: A Review
Abu Hassan Nordin, Siti Muhamad Nur Husna, Zuliahani Ahmad, et al.
Gels (2023) Vol. 9, Iss. 3, pp. 227-227
Open Access | Times Cited: 2
Abu Hassan Nordin, Siti Muhamad Nur Husna, Zuliahani Ahmad, et al.
Gels (2023) Vol. 9, Iss. 3, pp. 227-227
Open Access | Times Cited: 2
Advanced drug delivery systems in the treatment of chronic respiratory disorders
Chukwuebuka Emmanuel Umeyor, Popat Kumbhar, T C Okeke, et al.
Elsevier eBooks (2024), pp. 99-144
Closed Access
Chukwuebuka Emmanuel Umeyor, Popat Kumbhar, T C Okeke, et al.
Elsevier eBooks (2024), pp. 99-144
Closed Access
Chitosan-Based Drug Delivery Systems for Respiratory Diseases
C. Sarath Chandran, Krishnameera Sajayan, Shijina Kappally, et al.
(2023), pp. 201-215
Closed Access
C. Sarath Chandran, Krishnameera Sajayan, Shijina Kappally, et al.
(2023), pp. 201-215
Closed Access
Effect of Chitosan (Chi)-C Terminal 30 Amino Acids of Clostridium Perfringens Enterotoxin (CPE30)-pVP1 Nanoparticles on Rats with Viral Myocarditis
Yubin Zhang, Miaomiao Du, Xu Dexing
Science of Advanced Materials (2023) Vol. 15, Iss. 12, pp. 1611-1620
Closed Access
Yubin Zhang, Miaomiao Du, Xu Dexing
Science of Advanced Materials (2023) Vol. 15, Iss. 12, pp. 1611-1620
Closed Access
N-dihydrogalactochitosan reduces mortality in a lethal mouse model of SARS-CoV-2
Christopher M. Weiss, H. Liu, Erin E. Ball, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access
Christopher M. Weiss, H. Liu, Erin E. Ball, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access
